ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. - Concepedia

Concepedia

Publication | Closed Access

ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.

56

Citations

18

References

2009

Year

Richard Woessner, Brian Tunquist, Christine Lemieux, Elizabeth A. Chlipala, Steve Jackinsky, Walter E. DeWolf, W.C. Voegtli, April Cox, Sumeet Rana, Patrice Lee,

Abstract

The data provide a rationale for clinical evaluation of the activity of ARRY-520 in hematological carcinomas and taxane-resistant tumors.

References

	Year	Citations

Page 1